Peptides Or Polypeptides, Or Derivatives Thereof Patents (Class 506/18)
-
Publication number: 20150011411Abstract: The present invention relates to identification of a transcriptional signature of RalA and RalB GTPase proteins that is present in human cancer cells, and methods of treating the cancer, methods of diagnosis of the cancer, methods of determining predisposition to the cancer, methods of monitoring progression/regression of the cancer, methods of assessing efficacy of compositions for treating the cancer, methods of screening compositions for activity in modulating biomarker of the cancer, as well as other methods and assay systems based on the signature.Type: ApplicationFiled: December 21, 2012Publication date: January 8, 2015Inventors: Dan Theodorescu, Alex Baras, Steven Smith
-
Publication number: 20150011405Abstract: Disclosed herein are methods and compositions for using nanoexpression to interrogate antigen specificity within antibody repertoires. Also disclosed herein is an antibody display system composition comprising one or more recombinant nucleic acid sequences comprising a first nucleic acid sequence encoding a heavy chain variable region sequence or fragment thereof operatively linked to a first identification region sequence and a second nucleic acid sequence encoding a light chain variable region sequence or fragment thereof operatively linked to a second identification region sequence.Type: ApplicationFiled: June 30, 2014Publication date: January 8, 2015Inventors: Jeff DeFalco, Tito Serafini, Wayne Volkmuth
-
Publication number: 20150011428Abstract: Surface modifications to sensors in an array give the sensors different functionalities for adsorbing or binding molecules. A first sensor in the array includes a first resonating member having a first surface comprising a polymer receptor material coated over a first underlying material. A second sensor includes a second resonating member having a second surface comprising the polymer receptor material coated over a second underlying material that is different than the first underlying material. The first underlying material, the second underlying material, and the polymer receptor material are selected such that the first resonating member, having a combination of the polymer receptor material and the first underlying material, has a different ability to adsorb or bind a mass of one or more analytes than does the second resonating member having a combination of the polymer receptor material with the second underlying material. Methods for fabricating sensors with surface modifications are also provided.Type: ApplicationFiled: July 2, 2014Publication date: January 8, 2015Applicant: MATRIX SENSORS, INC.Inventors: Michael D. Cable, Heinrich Sussner, Steven Yamamoto
-
Publication number: 20150011412Abstract: The invention provides methods and systems for detecting a biomarker in a synovial fluid wherein the system also includes a control to ensure that the test sample is indeed synovial fluid. The biomarkers and the control for synovial fluid can be identified using proteomic methods, including but not limited to antibody based methods, such as an enzyme-linked immunosorbant assay (ELISA), a radioimmunoassay (RIA), or a lateral flow immunoassay.Type: ApplicationFiled: October 22, 2012Publication date: January 8, 2015Inventors: Carl Deirmengian, Richard C. Birkmeyer, Keith Kardos, Patrick Kilmartin, Alexander Cameron, Kevin Schiller, Eun Kyung Chung
-
Publication number: 20150011418Abstract: The present invention is a method for using levels of soluble Clusters of Differentiation (CD) proteins, or cell surface-localized CD proteins extracted from T lymphocytes for determining the immune status of a subject. The present invention also a kit containing a CD protein extraction means and at least one antibody which specifically binds a CD protein for use in carrying out the method of the invention.Type: ApplicationFiled: September 22, 2014Publication date: January 8, 2015Inventors: Jorn Gorlach, Jenifer Marie Gorlach
-
Publication number: 20150011421Abstract: An electrochemical method for measuring the activity of enzymes using nanoelectrode arrays fabricated with vertically aligned carbon nanofibers. Short peptide substrates specific to disease-related enzymes are covalently attached to the exposed nanofiber tips. A redox moiety, such as ferrocene, can be linked at the distal end of the nanofibers. Contact of the arrays with a biological sample containing one or more target enzymes results in cleavage of the peptides and changes the redox signal of the redox moiety indicating the presence of the target enzymes.Type: ApplicationFiled: June 30, 2014Publication date: January 8, 2015Inventors: Jun Li, Duy Hua, Lateef Uddin Syed, Allan Prior, Luxi Swisher
-
Patent number: 8927464Abstract: Fluidics-induced localized deposition and assembly of materials using a superhydrophobic surface structure is described. A method of localized deposition of a material includes contacting a superhydrophobic substrate comprising raised surface structures with a non-wetting fluid comprising a material to be locally deposited or a precursor thereto, said surface and said fluid selected such that the fluid wets only an upper portion of the raised surface structure; and allowing the material to deposit at the tips of the surface structure.Type: GrantFiled: December 1, 2008Date of Patent: January 6, 2015Assignee: President and Fellows of Harvard CollegeInventors: Joanna Aizenberg, Benjamin Hatton
-
Publication number: 20150005197Abstract: A photonic crystal-immunoassay platform wherein the periodicity of wells in an array are designed based on the leaky wave-guided modes of high refractive index material and a wavelength of excitation and/or emission of electromagnetic radiation associated with a signal used in the assay.Type: ApplicationFiled: January 7, 2013Publication date: January 1, 2015Applicant: The Regents of the University of CaliforniaInventors: Ian M. Kennedy, Jin-Hee Han, Sudheendra Lakshmana
-
Publication number: 20150005250Abstract: The subject invention pertains to methods and compositions for the detection and treatment of myelodysplastic syndromes based on impaired telomerase function.Type: ApplicationFiled: October 15, 2012Publication date: January 1, 2015Inventors: Dana E. Rollison, Pearlie K. Burnette
-
Publication number: 20150005192Abstract: The invention relates to a method of diagnosing or monitoring schizophrenia or other psychotic disorder.Type: ApplicationFiled: September 12, 2014Publication date: January 1, 2015Applicant: Cambridge Enterprise LimitedInventors: Sabine Bahn, Paul Guest, Laura Harris, Yishai Levin, Divya Krishnamurthy
-
Publication number: 20150005180Abstract: A biochip is provided that suppresses nonspecific adsorption or bonding of a detection target substance without coating with an adsorption inhibitor and that has excellent detection sensitivity. The constitution is such that it has a macromolecular substance containing a phosphorylcholine group and an active ester group on a substrate surface of a biochip substrate.Type: ApplicationFiled: September 17, 2004Publication date: January 1, 2015Inventors: Kazuhiko Ishihara, Sohei Funaoka, Kanehisa Yokoyama
-
Publication number: 20140378332Abstract: Provided herein are methods and devices for the detection of conditions or disorders by detecting altered levels of stress response pathway biomarkers. Also provided are methods and reagents for identifying panels of biomarkers associated with a condition or disorder.Type: ApplicationFiled: July 7, 2014Publication date: December 25, 2014Inventor: Sarka O. Southern
-
Publication number: 20140378347Abstract: Disclosed are methods for conducting diagnostic tests for the detection of the inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis. Also described are methods for monitoring a patient by administering tests of the present invention. Also described are methods for monitoring patient's treatment by administering tests of the present invention. Also described are methods for evaluating the effectiveness of a drug or a drug candidate by administering tests of the present invention to samples from patients, animal models, and cell cultures treated with a drug or a drug candidate. Also disclosed are methods for determining the usefulness of analytes, e.g. cytokines, for acting as diagnostic and monitoring markers for inflammatory bowel disease in the various methods of the invention.Type: ApplicationFiled: September 5, 2014Publication date: December 25, 2014Applicant: Meso Scale Technologies, LLCInventors: Jeff D. Debad, Eli N. Glezer, Sudeep M. Kumar
-
Publication number: 20140378342Abstract: Irrigation and/or aspiration devices and methods may be configured to aspirate and irrigate alone, sequentially, or concurrently. The devices and methods may provide a base with a removable head, and adapted for partial or complete separation of the irrigation and aspiration functions. The devices and methods can be configured to aspirate and/or irrigate the nasal and sinus cavities. The devices and methods may be manually and/or automatically controlled. The devices and methods may include removable, and/or replaceable, and/or refillable, and easily cleanable reservoirs for aspirant and irrigant. The device head and/or aspirant reservoir may comprise a diagnostic device, i.e., test device and/or container after use of the devices and methods.Type: ApplicationFiled: September 8, 2014Publication date: December 25, 2014Applicant: AARDVARK MEDICAL, INC.Inventors: Peter C. BAKER, Clinton N. SLONE, Michael J. STRASSER, James M. LOVETTE, Thomas KING, Richard TREADWELL
-
Publication number: 20140371098Abstract: The present invention relates to a method for identifying marker sequences for breast cancer, the marker sequences identified with the aid of this method and diagnostic use thereof, diagnostic devices containing marker sequences for breast cancer, in particular an arrangement and a protein array, and use thereof. The invention also relates to method for the screening of potential active agents for the treatment and prevention of breast cancer by means of these marker sequences.Type: ApplicationFiled: December 24, 2012Publication date: December 18, 2014Applicant: Protagen AGInventors: Angelika Lüking, Axel Kowald, Annabel Höpner, Christian Scheer, Heidelinde Fiegl, Günter Daxenbichler
-
Publication number: 20140371081Abstract: Biomarkers are provided for detecting, diagnosing and prognosing thymic cancer in individuals having or suspected of having thymic cancer. In addition, kits are provided for measuring expression levels or the presence of the biomarkers associated with thymic cancer for detecting, diagnosing and prognosing thymic cancer. Furthermore, methods are provided for detecting, diagnosing and prognosing thymic cancer in individuals having or suspected of having thymic cancer via the biomarkers.Type: ApplicationFiled: June 22, 2013Publication date: December 18, 2014Applicants: Indiana University Research and Technology Corporation, Castle Biosciences IncorporatedInventors: Sunil Badve, Yesim Gokmen-Polar, Patrick J. Loehrer, Robert Cook, Derek Maetzold
-
Publication number: 20140371106Abstract: The invention provides light-emitting compositions, including lasing and fluorescent compositions. The invention particularly relates to programmable biological substrates, which fluoresce and/or lase, and which have a wide variety of different applications. The invention extends to use of the fluorescent compositions and lasing compositions comprising programmable biological substrates in fabricating lasers, and in various biological imaging applications, such as in assays.Type: ApplicationFiled: December 21, 2012Publication date: December 18, 2014Applicant: UCL BUSINESS PLCInventors: John Edward Hales, John Ward, Gabriel Aeppli, Tim Dafforn
-
Publication number: 20140371097Abstract: The present invention provides methods of selecting oocytes for in vitro fertilization comprising determining the level of translation products in medium in which the oocyte is incubate.Type: ApplicationFiled: December 21, 2012Publication date: December 18, 2014Inventors: Marco Conti, Alberuni Musa Zamah, Jing Chen
-
Publication number: 20140371095Abstract: The present invention relates to a novel method for identifying specific marker sequences for diagnosis of prostate cancer and/or for prognosis in prostate cancer, and to the use of the specific marker sequences identified with the aid of this method.Type: ApplicationFiled: November 14, 2012Publication date: December 18, 2014Applicant: Protagen AGInventors: Peter Amersdorfer, Angelika Lueking, Axel Kowald, Bettina Schlick, Petra Massoner, Christof Seifart, Georg Schäfer, Helmut Klocker, Peter Schulz-Knappe, Klaus Marquart
-
Publication number: 20140371091Abstract: Biomolecule arrays on a substrate are described which contain a plurality of biomolecules, such as coding nucleic acids and/or isolated polypeptides, at a plurality of discrete, isolated, locations. The arrays can be used, for example, in high throughput genomics and proteomics for specific uses including, but not limited molecular diagnostics for early detection, diagnosis, treatment, prognosis, monitoring clinical response, and protein crystallography.Type: ApplicationFiled: October 24, 2012Publication date: December 18, 2014Inventors: Peter Wiktor, Joshua Labaer, Peter Kahn, Bharath Takulapalli, Ji Qiu, Al Brunner, Mitch Magee
-
Publication number: 20140364326Abstract: The present invention relates to compositions and methods for detecting, managing or monitoring cancer. The invention also relates to antibodies specific for cancer markers, compositions and chips containing the same, as well as their uses for cancer detection, managing, monitoring, imaging or treatment, as well as for drug development. The invention is particularly suited for detecting, managing or monitoring lung cancer in human subjects.Type: ApplicationFiled: January 30, 2012Publication date: December 11, 2014Applicant: F. HOFFMANN-LA ROCHE SAInventors: Mariana Guergova-Kuras, Yann Kieffer, Carole Malderez-Bloes, Alexandra Kremeurt, Laszlo Takacs
-
Publication number: 20140364334Abstract: The invention provides gene and protein markers for cardiac disease and methods for using them to identify patients at risk for developing heart failure, or patients in an early stage of heart failure whose disease is likely to advance to a later stage. The present invention allows a treatment provider to identify those patients whose disease is most likely to develop and/or advance, and to initiate and/or adjust treatment options for such patients accordingly.Type: ApplicationFiled: December 20, 2012Publication date: December 11, 2014Inventor: Patrick J. Muraca
-
Publication number: 20140364325Abstract: A sensor array includes resonator sensors having respective receptor materials disposed thereon. The receptor materials have a physical property relevant to their ability to bind or adsorb one or more analytes in a sample. The physical property of the receptor materials on the sensors systematically increases or decreases in degree from one sensor to the next in the array. The device also comprises at least one detector for detecting sensor responses when masses of the analytes are adsorbed or bound to the receptor materials on the sensors. With this graded panel of sensors in the array, the analytes may adsorb or bind to the functionalized sensors with a pattern of responses specific to each analyte.Type: ApplicationFiled: June 5, 2013Publication date: December 11, 2014Inventors: Michael D Cable, Heinrich Sussner
-
Publication number: 20140364330Abstract: The invention provides a bio-sensing nanodevice comprising: a stabilized G-protein coupled receptor on a support, a real time receptor-ligand binding detection method, a test composition delivery system and a test composition recognition program. The G-protein coupled receptor can be stabilized using surfactant peptide. The nanodevice provides a greater surface area for better precision and sensitivity to odorant detection. The invention further provides a microfluidic chip containing a stabilized G-protein coupled receptor immobilized on a support, and arranged in at least two dimensional microarray system. The invention also provides a method of delivering odorant comprising the step of manipulating the bubbles in complex microfluidic networks wherein the bubbles travel in a microfluidic channel carrying a variety of gas samples to a precise location on a chip. The invention further provides method of fabricating hOR17-4 olfactory receptor.Type: ApplicationFiled: June 9, 2014Publication date: December 11, 2014Inventors: Andreas Mershin, Brian Cook, Liselotte Kaiser, Johanna F. Bikker, Yoshikatsu Miura, Daisuke Niwa, Dai Ohnishi, Atsushi Tazuke, Shuguang Zhang
-
Publication number: 20140364332Abstract: The invention provides compositions (e.g., peptide compositions) useful for the detection of antibodies that bind to Borrelia antigens. The peptide compositions comprise polypeptide sequences comprising variants in the IR6 domain of the Borrelia VlsE protein. The invention also provides devices, methods, and kits comprising such peptide compositions and useful for the detection of antibodies that bind to Borrelia antigens and the diagnosis of Lyme disease.Type: ApplicationFiled: June 13, 2014Publication date: December 11, 2014Inventors: Rajesh K. MEHRA, Kenneth P. ARON, Dennis M. BLEILE, Jeremy WALKER, Cristina CUESICO
-
Publication number: 20140364328Abstract: The present invention provides methods, compositions and kits for the detection of Parkinson' disease (PD) diagnostic biomarkers, for the diagnosis of PD, for the identification of a subject at risk for developing PD, and for the generation of patient-specific PD diagnostic biomarker profiles.Type: ApplicationFiled: August 10, 2012Publication date: December 11, 2014Applicant: ROWAN UNIVERSITYInventor: Robert G. Nagele
-
Publication number: 20140364337Abstract: A method for absolute protein or peptide quantitation by mass spectroscopy. A sample containing a protein or peptide of interest is prepared for mass spectroscopy analysis. The sample is subjected to mass spectroscopy analysis at low resolution whereby a single additive mass spectroscopy peak is obtained, then is subjected to high resolution mass spectroscopy analysis whereby a plurality of mass spectroscopy peaks are obtained. The intensity of each of the plurality of mass spectroscopy peaks is quantitated either by comparison to an internal standard set, or by using a standard curve generated for each isotopologue set. Quantitation using a standard curve enhances quantitation across a dynamic range of analyte.Type: ApplicationFiled: June 6, 2014Publication date: December 11, 2014Inventors: Greg Hermanson, John Charles Rogers, Joel Louette, Ryan Daniel Bomgarden, Bhavinkumar Patel
-
Publication number: 20140364341Abstract: Methods are provided for predicting the presence, subtype and stage of ovarian cancer, as well as for assessing the therapeutic efficacy of a cancer treatment and determining whether a subject potentially is developing cancer. Associated test kits, computer and analytical systems as well as software and diagnostic models are also provided.Type: ApplicationFiled: August 21, 2014Publication date: December 11, 2014Inventors: Brian C. Mansfield, Ping F. Yip, Suraj Amonkar, Greg P. Bertenshaw
-
Publication number: 20140357524Abstract: There is provided a method for quantifying a subject substance, of which typical examples are amino acids. The method of the present invention comprises the following steps: the step of allowing an enzyme that can generate pyrophosphate by using adenosine triphosphate (ATP) as a substrate with converting the subject substance to act on the subject substance to generate pyrophosphate; the step of allowing pyruvate pyrophosphate dikinase (PPDK) to act on the generated pyrophosphate in the presence of adenosine monophosphate (AMP) and phosphoenolpyruvate (PEP) to generate ATP, phosphoric acid, and pyruvate; and the step of quantifying the generated pyruvate, and amount of the subject substance is determined on the basis of the obtained amount of pyruvate. According to the present invention, an amino acid in a biological sample containing a lot of various kinds of contaminants such as inorganic phosphoric acid and urea can be conveniently and quickly quantified without being influenced by the contaminants.Type: ApplicationFiled: August 6, 2014Publication date: December 4, 2014Applicants: AJINOMOTO CO., INC., TOYAMA PREFECTUREInventors: Yasuhisa Asano, Masafumi Kameya
-
Publication number: 20140357504Abstract: A system and methods for consumer use of a microarray product are provided. A method includes obtaining a microarray product and contacting the microarray product with a sample and performing bioassays. The method further includes obtaining a decoding information data package from a manufacturer of the microarray product for correlating bioassay signals from the bioassays with respective analytes, wherein the microarray product is obtained at a first time different and discrete from a second time that the decoding information data package is obtained.Type: ApplicationFiled: June 2, 2013Publication date: December 4, 2014Inventors: Dieter Trau, Andreas Schmidt
-
Publication number: 20140357660Abstract: Gene signatures for determining whether a neoplasm (such as a multiple myeloma neoplasm) is sensitive to mTORi/HDACi combination therapy and/or for determining the prognosis of a neoplasm in a subject are described. Some embodiments include determining whether a neoplasm is sensitive to mTORi/HDACi combination therapy by predicting whether mTORi/HDACi combination therapy will successfully treat the neoplasm, for example increasing survival of the subject with the neoplasm. In some embodiments, determining the prognosis includes predicting the outcome (such as chance of survival) of the subject with a neoplasm. Also disclosed are reagents, for example arrays, for use with the disclosed methods, as well as computer implementation of the disclosed methods.Type: ApplicationFiled: November 12, 2012Publication date: December 4, 2014Inventors: Beverly A. Mock, John K. Simmons, Aleksandra Michalowski, Jyoti Patel
-
Publication number: 20140357514Abstract: A generally applicable method for the selective covalent attachment of a reporter molecule to a replicating entity that allows one to obtain specific binders from a single round of library screening is disclosed. For example, selective biotinylation of phage particles and yeast cells displaying a binder to any given target can be achieved via application of a coupled enzyme reaction that includes a peroxidase, an oxidase and a catalase.Type: ApplicationFiled: December 14, 2012Publication date: December 4, 2014Inventors: Stefan Becker, Tim Heiseler, Alexander Maass, Harald Kolmar
-
Publication number: 20140349877Abstract: Methods and compositions for detecting and diagnosing Parkinson's disease are disclosed.Type: ApplicationFiled: December 7, 2012Publication date: November 27, 2014Inventors: Howard E. Gendelman, R. Lee Mosley, Jessica A. Saunders
-
Publication number: 20140349857Abstract: The present invention relates to a method for in vitro diagnosis or prognosis of colon cancer, including a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said isolated nucleic acid sequences as a molecular marker/molecular markers, and a kit including at least one specific binding partner for at least one expression product of the HERV nucleic acid sequences.Type: ApplicationFiled: December 17, 2012Publication date: November 27, 2014Inventors: François Mallet, Nathalie Mugnier, Philippe Perot
-
Publication number: 20140349863Abstract: Assays for detecting anti-streptococcal antibodies in biological samples using one or more streptococcal antigens are described herein. Various combinations of antigens may be used in the assays. For example, one or more of Ply, PhtD, PhtE, LytB and PcpA may be utilized. Additional streptococcal antigens may also be used. The assays may also be used in combination with assays that detect streptococcal nucleic acids.Type: ApplicationFiled: March 1, 2013Publication date: November 27, 2014Applicant: Sanofi Pasteur LimitedInventors: Martina Ochs-Onolemhemhen, Roger Brookes, Claire-Anne Siegrest
-
Publication number: 20140348762Abstract: Described herein are methods for identifying a mammal having a heightened susceptibility to enamel erosion, together with kits therefor and uses and methods related thereto.Type: ApplicationFiled: December 20, 2011Publication date: November 27, 2014Applicant: COLGATE-PALMOLIVE COMPANYInventors: Lynette Zaidel, Steven Miller, Guy Carpenter, Gordon Proctor, David Bartlett, Rebecca Moazzez
-
Publication number: 20140349888Abstract: Disclosed herein are formulations, substrates, and arrays. Also disclosed herein are methods for manufacturing and using the formulations, substrates, and arrays. Also disclosed are methods for identifying peptide sequences useful for diagnosis and treatment of disorders, and methods for using the peptide sequences for diagnosis and treatment of disorders, e.g., celiac disorder. In certain embodiments, substrates and arrays comprise a porous layer for synthesis and attachment of polymers or biomolecules.Type: ApplicationFiled: August 7, 2014Publication date: November 27, 2014Inventors: John J. Rajasekaran, Vasanth Jayaraman, Tianhao Wang, Kang Bei, Hari Krishnan Krishnamurthy
-
Publication number: 20140349881Abstract: The application discloses new test panels comprising biomarkers and clinical parameters, for the prediction, diagnosis, prognosis and/or monitoring of hypertensive disorders of pregnancy and particularly preeclampsia; and related methods, uses, kits and devices.Type: ApplicationFiled: December 14, 2012Publication date: November 27, 2014Inventors: Gregoire Thomas, Robin Tuytten, Piet Moerman
-
Publication number: 20140342939Abstract: The present invention relates to methods and kits for diagnosing systemic lupus erythematosus (SLE) in a subject. Particularly, the present invention relates to a specific antibody profile useful in diagnosing SLE in a subject.Type: ApplicationFiled: July 31, 2014Publication date: November 20, 2014Inventors: Irun R. Cohen, Eytan Domany, Noam Shental, Ittai Fattal
-
Publication number: 20140342923Abstract: The present invention relates to biomarker signatures and associated methods for identifying patients that are not likely to manifest significant coronary artery disease. It is based, at least in part, on a study performed on serum samples of 239 patients with clinical symptoms of cardiac distress, some of whom required invasive intervention (stent placement or bypass graft surgery). A set of biomarkers was identified as exhibiting different levels of expression in subjects that did, or did not, require invasive intervention. Further, an algorithm was developed which, using serum levels of these biomarkers, assigned a score to a given patient that was indicative of whether that patient required invasive intervention.Type: ApplicationFiled: June 5, 2013Publication date: November 20, 2014Inventors: William A. LAFramboise, Masterson Robert V., Oscar C. Marroquin, Dennis M. McNamara, Suresh R. Mulukutla, Aleksey Lomakin
-
Publication number: 20140342927Abstract: The invention relates to a method of identifying a specific fungal species in patient tissue or body fluid. The method comprises the steps of extracting and recovering DNA of the fungal species from the patient tissue or body fluid, amplifying the DNA, hybridizing a probe to the DNA to specifically identify the fungal species, and specifically identifying the fungal species. The invention also relates to a method of identifying a mycotoxin in patient tissue or body fluid. The method comprises the steps of extracting and recovering the mycotoxin from the patient tissue or body fluid, contacting the mycotoxin with an antibody directed against the mycotoxin, and identifying the myocotoxin. Both of these methods can be used to determine if a patient is at risk for or has developed a disease state related to a fungal infection, and to develop an effective treatment regimen for the patient.Type: ApplicationFiled: April 18, 2014Publication date: November 20, 2014Applicant: Medical Service Consultation International LLCInventor: Dennis G. HOOPER
-
Publication number: 20140342936Abstract: The present invention relates to a method for diagnosing latent tuberculosis infection in a subject comprising the step i) consisting of incubating a biological sample obtained from the subject with at least one Mycobacterium tuberculosis antigen, and thereafter a step ii) consisting of quantifying in said biological sample the secretion of at least one cytokine selected from the group consisting of IL-2, IL-15, IP-10 and MIG.Type: ApplicationFiled: December 17, 2012Publication date: November 20, 2014Inventors: Pierre-Alain Rubbo, Nicolas Nagot, Edouard Tuaillon, Philippe Van De Perre
-
Publication number: 20140342947Abstract: The present invention provides a formulation to link protein to a solid support that comprises one or more proteins, Oligo-dT and one or more non-volatile, water-soluble protein solvents, solutes or combination thereof in an aqueous solution. Further provided is a method of attaching a protein to a surface of a substrate. The formulations provided herein are contacted onto the substrate surface, printed thereon and air dried. The substrate surface is irradiated with UV light to induce thymidine photochemical crosslinking via the thymidine moieties of the Oligo-dT.Type: ApplicationFiled: May 14, 2014Publication date: November 20, 2014Inventor: Michael E. Hogan
-
Publication number: 20140336081Abstract: A substrate for biochips which has a high probe loading amounts and a uniform immobilization density, and which further has a high detection sensitivity and a high reproducibility by preventing a non-specific adsorption of proteins, when used as a substrate for biochips for immobilizing probes composed of biologically relevant substances such as proteins and nucleic acids, is disclosed. Amino groups can be bound to the surface of the substrate uniformly, at a high density and stably by covalently immobilizing an amino group-containing polymer on the surface of the substrate. The probe immobilization rate is high and immobilizing density was uniform by immobilizing a probe composed of a biologically relevant substance such as a protein or nucleic acid by utilizing the amino groups. Further, detection sensitivity and reproducibility are high by inhibiting non-specific adsorption of proteins.Type: ApplicationFiled: July 22, 2014Publication date: November 13, 2014Applicants: NIPPON LIGHT METAL COMPANY, LTD., HIPEP LABORATORIESInventors: Kiyoshi NOKIHARA, Akiyoshi HIRATA, Yasuo OKA, Yasushi TAKEBAYASHI
-
Publication number: 20140336065Abstract: The methods and kits described herein are based, in part, to the discovery of a phenotype representing a fully-reprogrammed iPS cell and several reprogramming intermediates. The methods and kits described herein permit identification of fully-reprogrammed iPS cells and further permits one of skill in the art to monitor the emergence of iPS cells during the reprogramming process. The methods/kits can also be performed using real time using live cell imaging. Also described herein are methods for screening candidate reprogramming agents by monitoring the emergence of fully-reprogrammed iPS cells in the presence and absence of such an agent.Type: ApplicationFiled: February 28, 2014Publication date: November 13, 2014Applicant: Children's Medical Center CorporationInventors: George Q. Daley, In-Hyun Park, Thorsten M. Schlaeger, Elayne Chan, Sutheera Ratanasirintrawoot
-
Publication number: 20140335102Abstract: Methods are disclosed for increasing the binding affinity of binding proteins using in silico affinity maturation.Type: ApplicationFiled: December 18, 2012Publication date: November 13, 2014Applicant: SanofiInventors: Michael Oberlin, Romano Kroemer, Vincent Mikol, Hervé Minoux, Nicolas Baurin
-
Publication number: 20140336077Abstract: A method of recognizing the development of an Acute Myocardial Infarction (AMI) process in an individual, wherein the method comprises steps of: profiling specific antibody reactivities or biomarkers associated with AMI susceptibility, the profiling comprises steps of: attaching a set of defined antigens to a substrate; obtaining a biological fluid derived specimen from an individual, the specimen containing a specific antibody repertoire; and binding said antibodies of the biological fluid specimen to the attached antigens thereby forming bound antibody antigen complexes; and analyzing results obtained, wherein the presence of the complexes is indicative of AMI.Type: ApplicationFiled: July 29, 2014Publication date: November 13, 2014Inventors: Irun R. Cohen, Eytan Domany, Eli Sahar, Noam Shental
-
Publication number: 20140336072Abstract: A platform for biological assays includes a base substrate providing structural support to the platform, at least one surface of the base substrate coated with position markers, a first deformable layer positioned on top of the base substrate, and a second deformable layer positioned on top of the first deformable layer, the second deformable layer embedded with deformation markers.Type: ApplicationFiled: November 16, 2012Publication date: November 13, 2014Inventors: Ramaswamy Krishnan, Allen Ehrlicher, James Butler, David A. Weitz, Jeffrey J. Fredberg, Chan Young Park
-
Publication number: 20140336068Abstract: The present invention provides methods of detecting an antigen in a sample comprising contacting the sample with affinity agents to form an antigen-affinity agent-label complex, separating the antigen-affinity agent-label complex from uncomplexed components, partitioning label from the separated sample into multiple partitions, and detecting the presence of the label in one or more partitions. Compositions and kits for detecting an antigen in a sample are also provided.Type: ApplicationFiled: May 7, 2014Publication date: November 13, 2014Applicant: Bio-Rad Laboratories, Inc.Inventors: Shawn Hodges, Nick Heredia, Jonathan Petersen
-
Publication number: 20140336071Abstract: This disclosure relates to compositions, devices and methods of detecting the presence of molecules and optionally quantifying forces associated with molecular interactions on the surface of cells and other lipids. In certain embodiments, devices disclosed herein can be used to detect forces through cell surface receptors. In other embodiments, the devices can be used to detect the presence or absence of molecules on cells or other particles or detect the changes in cell morphology after ligand receptor binding.Type: ApplicationFiled: September 28, 2012Publication date: November 13, 2014Applicant: EMORY UNIVERSITYInventors: Khalid S. Salaita, Carol Schumacher, Daniel R. Stabley